Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: A North American Brain Tumor Consortium study Article

Cloughesy, Timothy F, Wen, Patrick Y, Robins, H Ian et al. (2006). Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: A North American Brain Tumor Consortium study . JOURNAL OF CLINICAL ONCOLOGY, 24(22), 3651-3656. 10.1200/JCO.2006.06.2323

Open Access

cited authors

  • Cloughesy, Timothy F; Wen, Patrick Y; Robins, H Ian; Chang, Susan M; Groves, Morris D; Fink, Karen L; Junck, Larry; Schiff, David; Abrey, Lauren; Gilbert, Mark R; Lieberman, Frank; Kuhn, John; DeAngelis, Lisa M; Mehta, Minesh; Raizer, Jeff J; Yung, WK Alfred; Aldape, Ken; Wright, John; Lamborn, Kathleen R; Prados, Michael D

sustainable development goals

authors

publication date

  • August 1, 2006

webpage

published in

keywords

  • ANTICONVULSANTS
  • GLIOBLASTOMA-MULTIFORME
  • KINASE
  • Life Sciences & Biomedicine
  • Oncology
  • PACLITAXEL
  • Science & Technology
  • THERAPY
  • TRANSFERASE INHIBITOR R115777

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 3651

end page

  • 3656

volume

  • 24

issue

  • 22